Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» GS-7977
GS-7977
Gilead Shares Hit All-Time High On Positive Trial For Hep C Drug
Yahoo/Investors Business Daily
Tue, 11/13/12 - 11:13 am
hepatitis C
Gilead
GS-5885
GS-7977
Gilead Climbs on Study Results of Hepatitis C Combo
Bloomberg
Mon, 11/12/12 - 11:02 am
Gilead
hepatitis C
sofosbuvir
GS-5885
GS-7977
5 Things to Watch This Week in the Health-Care Sector
Motley Fool
Mon, 10/22/12 - 10:52 am
Regeneron
Eyela
Gilead
GS-7977
Merck
Eli Lilly
Singulair
Molina Healthcare
Blockbuster buzz: 15 top therapies in late-stage development
Fierce Biotech
Thu, 10/11/12 - 10:49 am
vortioxetine
Vectura
tofacitinib
Takeda
T-DM1
Sanofi
Roche
REGN727
Regeneron
Reata
QVA149
Pfizer
Odanacatib
Novartis
MorphoSys
Merck
macitentan
Lundbeck
Immunogen
GSK
GS-7977
Gilead
gantenerumab
Eliquis
darapladib
Bristol-Myers Squibb
Biogen Idec
BG-12
Bayer
Bardoxolone
Anacetrapib
Alpharadin
Algeta
Actelion
AbbVie
Gilead Sciences Makes Headlines With HIV Prevention Pill, Looks to Hepatitis Drugs for Future
Minyanville
Fri, 09/14/12 - 12:23 pm
Gilead
HIV
hepatitis C
GS-7977
Truvada
Guilt by Association = 30% Slaughter?
Motley Fool
Sun, 08/19/12 - 11:27 am
IDX184
hepatitis C
Idenix
GS-7977
Gilead Sciences
Vertex Pharmaceuticals
Forget the Numbers, This Pipeline Is King
Motley Fool
Sat, 07/28/12 - 11:15 am
Gilead Sciences
Quad
HIV
GS-7977
hepatitis C
Gilead Begins Single Pill Hepatitis C Study For 2014 Approval
Bloomberg
Fri, 07/27/12 - 12:02 pm
GS-7977
hepatitis C
Gilead
Bristol CEO says Gilead holding out on hep C tie-up
Fierce Biotech
Fri, 06/1/12 - 12:30 pm
Bristol-Myers Squibb
Gilead
hepatitis C
Lamberto Andreotti
daclatasvir
GS-7977
Gilead's Hepatitis C Drug Poised To Reach The Market As One Of The First 'All Oral' Combinations
Seeking Alpha
Sun, 04/22/12 - 12:04 pm
Gilead Sciences
GS-7977
hepatitis C
Gilead, Bristol Shine at EASL Conference
Motley Fool
Sun, 04/22/12 - 12:02 pm
Gilead Sciences
Bristol-Myers Squibb
GS-7977
daclatasvir
hepatitis C
Celebrate the Hep C Wins, for Now
Motley Fool
Sat, 04/21/12 - 12:26 pm
hepatitis C
Gilead Sciences
GS-7977
daclatasvir
Bristol-Myers Squibb
Abbott Laboratories
Vertex Pharmaceuticals
Incivek
Partner Up or Get Passed Up
Motley Fool
Sat, 04/21/12 - 11:51 am
GS-7977
Vertex Pharmaceuticals
hepatitis C
Roche
Bristol-Myers Squibb
Merck
Gilead Sciences
JNJ
Gilead Rises After Hepatitis Data Open New Test Options
Bloomberg
Thu, 04/19/12 - 11:43 am
hepatitis C
Gilead
Bristol-Myers Squibb
GS-7977
Gilead Sciences' Hepatitis Drug in Spotlight at Major Medical Meeting
Minyanville
Fri, 04/13/12 - 09:52 am
hepatitis C
Gilead
GS-7977
Gilead Bets on Hepatitis C Data to Back Pharmasset Deal
Bloomberg
Thu, 04/12/12 - 11:35 am
Gilead
hepatitis C
Pharmasset
BMS-790052
GS-7977
Bristol-Gilead Hep C Drug Data Leaks
TheStreet.com
Mon, 04/9/12 - 12:01 pm
Gilead
hepatitis C
Bristol-Myers Squibb
daclatasvir
GS-7977
1 Biotech Punished by Hep-C Overreaction
Motley Fool
Sat, 02/18/12 - 12:40 pm
Gilead Sciences
hepatitis C
GS-7977
Achillion, Vertex rally on Gilead's woes
Marketwatch
Fri, 02/17/12 - 01:17 pm
Vertex
Gilead
Achillion
GS-7977
protease inhibitors
hepatitis C
Gilead Suffers First Hep C Drug Setback
TheStreet.com
Fri, 02/17/12 - 09:05 am
Gilead
hepatitis C
GS-7977